Status | Study |
Recruiting |
Study Name: Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease Condition: Cushings Disease Date: 2014-09-26 Interventions: Drug: SOM230 |
Completed |
Study Name: The Factors Associated With the Recurrence in Patients With Cushing Disease Condition: Cushing Disease Date: 2014-08-27 |
Recruiting |
Study Name: Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease Condition: Cushing's Disease Date: 2014-06-17 Interventions: Drug: LCI699 |
Recruiting |
Study Name: Treatment of Cushing's Disease With R-roscovitine Condition: Cushings Disease Date: 2014-05-21 Interventions: Drug: R-roscovitine See Arm Description Other Names: |
Recruiting |
Study Name: Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly Condition: Cushing's Disease Acromegaly Date: 2014-02-10 Interventions: Drug: Pasireotide s.c. To be a |
Withdrawn |
Study Name: Mifepristone in Children With Refractory Cushing's Disease Condition: Cushing's Disease Date: 2013-08-08 Interventions: Drug: mifepristone tablets Other Name: Korlym |
Active, not recruiting |
Study Name: Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease Condition: Cushing's Disease Date: 2013-06-10 Interventions: Drug: Pasireotide with or without cabergoline The trial consists of Pasireotide-untreated patients will |
Recruiting |
Study Name: Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study. Condition: Cushing's Disease Acromegaly Date: 2013-02-15 Interventions: Drug: Pasireotide Pasireotide subcutaneous or Long Acting Release |
Recruiting |
Study Name: Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools Condition: Pituitary Neoplasms Prolactinoma ACT Date: 2013-01-22 Interventions: Other: Educational Intervention A brochure and access to a website including videos that contain detaile |
Terminated |
Study Name: Pasireotide Therapy in Patients With Nelson's Syndrome Condition: Nelson Syndrome Date: 2012-06-08 Interventions: Drug: Pasireotide 4 Weeks pasireotide 0.6mg s/c injections twice daily followed by 24 weeks treatment wi |